Phibro Animal Health (PAHC) Treasury Shares (2018 - 2026)

Phibro Animal Health (PAHC) recorded quarterly Treasury Shares of $650524.0 in Q1 2026, down 4.64% quarter-over-quarter from $682162.0 in Q4 2025, and up 14.13% on a YoY basis from $570000.0 in Q1 2025.

Phibro Animal Health (PAHC) Treasury Shares (2018 - 2026) Analysis & Trends

Phibro Animal Health's Treasury Shares history runs 5 years deep, the most recent figure standing at $650524.0 for Q1 2026.

  • In Q1 2026, Treasury Shares rose 14.13% year-over-year to $650524.0; the TTM figure through Mar 2026 stood at $650524.0 (up 14.13% YoY), while the FY2025 annual figure was $570000.0, changed N/A from the prior year.
  • Treasury Shares was $650524.0 for Q1 2026 at Phibro Animal Health, down from $682162.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $683847.0 in Q3 2025 to a low of $570000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 107.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 4.80 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 1.42 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 17.13 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 19.58 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 7.24 Mn
10 Phibro Animal Health 1.32 Bn 1.24 Bn 125.68 Mn 650,524.00

Historic Data

Download Data
DateValue
Mar 31, 2026 650,524.00
Mar 31, 2026 650,524.00
Dec 31, 2025 682,162.00
Dec 31, 2025 682,162.00
Sep 30, 2025 683,847.00
Sep 30, 2025 683,847.00
Jun 30, 2025 570,000.00
Jun 30, 2025 570,000.00
Mar 31, 2025 570,000.00
Mar 31, 2025 570,000.00
Jun 30, 2020 250,000.00
Jun 30, 2020 250,000.00
Jun 30, 2019 250,000.00
Jun 30, 2019 250,000.00
Jun 30, 2018 250,000.00
Jun 30, 2018 250,000.00